Verrica Pharmaceuticals Inc. (VRCA) Social Stream
VERRICA PHARMACEUTICALS INC (VRCA) Price Targets From Analysts
Use the tables below to see what analysts covering VERRICA PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 6 | $25 | $16 | $19.833 | $6.72 | 195.13% |
| 2021-12-16 | 6 | $25 | $16 | $19.5 | $6.72 | 190.18% |
| 2022-03-03 | 4 | $25 | $16 | $19.5 | $6.72 | 190.18% |
| 2022-03-07 | 5 | $25 | $16 | $19.5 | $6.72 | 190.18% |
| 2022-03-09 | 6 | $25 | $16 | $19.571 | $6.72 | 191.24% |
| 2022-05-09 | 5 | $25 | $16 | $19.285 | $6.72 | 186.98% |
| 2022-05-25 | 6 | $25 | $4 | $16.714 | $6.72 | 148.72% |
| 2022-05-27 | 6 | $20 | $4 | $15.285 | $6.72 | 127.46% |
| 2022-05-31 | 6 | $20 | $4 | $14.142 | $6.72 | 110.45% |
| 2022-08-11 | 5 | $20 | $4 | $13.166 | $6.72 | 95.92% |
| 2022-08-12 | 5 | $20 | $4 | $13 | $6.72 | 93.45% |
| 2023-01-25 | 5 | $18 | $4 | $11.6 | $6.72 | 72.62% |
| 2023-02-27 | 5 | $18 | $4 | $12.2 | $6.72 | 81.55% |
| 2023-03-06 | 5 | $15 | $4 | $10.75 | $6.72 | 59.97% |
| 2023-03-07 | 6 | $15 | $11 | $12.5 | $6.72 | 86.01% |
| 2023-03-22 | 6 | $13 | $10 | $11.25 | $6.72 | 67.41% |
| 2023-05-09 | 6 | $15.001 | $10 | $12 | $6.72 | 78.57% |
| 2023-05-10 | 6 | $15 | $10 | $12 | $6.72 | 78.57% |
| 2023-07-17 | 5 | $15 | $10 | $12 | $6.72 | 78.57% |
| 2023-07-25 | 6 | $15 | $10 | $11.666 | $6.72 | 73.6% |
| 2023-07-27 | 6 | $15 | $10 | $11.833 | $6.72 | 76.09% |
| 2023-08-10 | 6 | $15 | $10 | $12.166 | $6.72 | 81.04% |
| 2023-11-10 | 6 | $15 | $10 | $12.666 | $6.72 | 88.48% |
| 2023-11-20 | 6 | $18 | $8 | $12.833 | $6.72 | 90.97% |
The Trend in the Analyst Price Target
VRCA's average price target has moved down $1.31 over the prior 18 months.
Over the past 43 weeks, VRCA's average upside potential has been 132.44%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-22 | 6 | 13 | 10 | 11.250 | 6.370 | 76.61% |
| 2023-06-26 | 5 | 15 | 10 | 12.000 | 5.500 | 118.18% |
| 2023-10-12 | 6 | 15 | 10 | 12.666 | 3.650 | 247.01% |
| 2023-11-10 | 6 | 15 | 10 | 12.666 | 3.075 | 311.9% |
| 2023-11-20 | 6 | 18 | 8 | 12.833 | 3.710 | 245.9% |
VRCA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 4 | 2 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
VRCA's average broker recommendation rating worsened by 0.33 over the prior 45 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- VERRICA PHARMACEUTICALS INC's average analyst price target is higher than 489.81% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, VERRICA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 2240.52% of them.
- VERRICA PHARMACEUTICALS INC's number of analysts covering the stock is greater than 671.8% of all US stocks.
- In the context of Pharmaceutical Products stocks, VERRICA PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1122.33% of them.
In the Pharmaceutical Products industry, ITRM, SLGL, and COGT are the three stocks most similar to VERRICA PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding VRCA using the data that counts. Try POWR Ratings for free.